Heparin coated stents are small elastic tubes that possess a unique heparin surface. Heparin coated stents prevent thrombotic occlusion of the stent, hemorrhagic complications, and restenosis. They are usually made of metal mesh and are implanted into the lumen of blood vessels or ducts to keep the passage open. A stent implant is commonly used to treat cardiac abnormalities such as blocked blood vessels.
MARKET DYNAMICS
The heparin coated stent market is driving due to the rapid growth due to rising geriatric population, who are highly susceptible to strokes and require stent implant for treatment. However, high specificity of heparin coated stents, exorbitant cost of heparin coated stent implant procedures, and stringent government regulations is likely to restraint the market growth during the forecast period. Moreover, technological advancements in stents such as polymer coatings is driving the market growth.
MARKET SCOPE
The "Heparin Coated Stent Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of heparin coated stent market with detailed market segmentation by type and application. The heparin coated stent market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in heparin coated stent market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The heparin coated stent market is segmented on the basis of type and application. Based on type, the market is segmented as retrograde stents, antegrade stents and internal (double-J) stents. On the basis of application, the market is categorized as lithotripsy, ureteroscopy, ureteroenoscopy and percutaneous nephrolithotomy.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the heparin coated stent market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The heparin coated stent market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting heparin coated stent market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the heparin coated stent market in these regions.
MARKET PLAYERS
The report covers key developments in the heparin coated stent market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from heparin coated stent market are anticipated to have lucrative growth opportunities in the future with the rising demand for heparin coated stent in the global market. Below mentioned is the list of few companies engaged in the heparin coated stent market.
The report also includes the profiles of key players in heparin coated stent market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Abbott Laboratories
- B. Braun Melsungen AG
- Biotronik SE and Co. KG
- Boston Scientific Corporation
- C.R. Bard, Inc.
- Elixir Medical Corporation
- Gore Medical
- Johnson and Johnson
- Microport Scientific Corporation
- Stentys SA
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.